NASDAQ:RCEL
AVITA Medical, Inc. Stock News
$8.27
+0.350 (+4.42%)
At Close: May 17, 2024
AVITA Therapeutics, Inc. (RCEL) CEO Mike Perry on Q2 2021 Results - Earnings Call Transcript
11:05pm, Thursday, 11'th Feb 2021
AVITA Therapeutics, Inc. (RCEL) CEO Mike Perry on Q2 2021 Results - Earnings Call Transcript
AVITA Medical Reports Full Second Quarter 2021 Financial Results
04:01pm, Thursday, 11'th Feb 2021
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 11, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH) (Company), a regenerative medicine company that is developing and commercializi
AVITA Medical to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
04:01pm, Wednesday, 03'rd Feb 2021
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 03, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a tech
AVITA Medical to Announce Fiscal Second Quarter 2021 Financial Results
04:01pm, Thursday, 28'th Jan 2021
VALENCIA, Calif. and MELBOURNE, Australia, Jan. 28, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a tech
AVITA Medical (RCEL) is Overbought: Is A Drop Coming?
09:02am, Friday, 22'nd Jan 2021
AVITA Medical, Inc. (RCEL) has moved higher as of late, but there could definitely be trouble on the horizon for this company.
AVITA Medical to Present at the J.P. Morgan 39th Annual Healthcare Conference
05:00pm, Monday, 28'th Dec 2020
VALENCIA, Calif. and MELBOURNE, Australia, Dec. 28, 2020 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a tech
AVITA Therapeutics to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference
04:01pm, Wednesday, 18'th Nov 2020
VALENCIA, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that
AVITA: COVID-19's Impact
11:57am, Tuesday, 17'th Nov 2020
AVITA's existing FDA-approved product is growing to become the standard of care in a $200 million market. The COVID-19 pandemic has been particularly disruptive for AVITA.
AVITA Therapeutics, Inc. (RCEL) CEO Michael Perry on Q1 2021 Results - Earnings Call Transcript
09:58pm, Tuesday, 10'th Nov 2020
AVITA Therapeutics, Inc. (RCEL) CEO Michael Perry on Q1 2021 Results - Earnings Call Transcript
AVITA Therapeutics, Inc. (RCEL) CEO Michael Perry On Q3 2020 Results - Quick Version Earnings Call Transcript.
06:48pm, Tuesday, 10'th Nov 2020
AVITA Therapeutics, Inc. (RCEL) CEO Michael Perry On Q3 2020 Results - Quick Version Earnings Call Transcript.
AVITA Therapeutics Reports First Quarter 2021 Financial Results
04:01pm, Tuesday, 10'th Nov 2020
VALENCIA, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that
AVITA Therapeutics, Inc. Announces Executive Change
10:30pm, Thursday, 05'th Nov 2020
VALENCIA, Calif. and MELBOURNE, Australia, Nov. 05, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a
Avita Therapeutics, Inc. Announces Correction of Time for the Adjourned 2020 Annual Stockholder Meeting
07:46am, Thursday, 05'th Nov 2020
VALENCIA, Calif, and MELBOURNE, Australia, Nov. 05, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a
AVITA Therapeutics Announces Date Change for First Quarter 2021 Earnings Release and Conference Call
04:01pm, Tuesday, 03'rd Nov 2020
VALENCIA, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that
AVITA Therapeutics, Inc. Announces Adjournment of 2020 Annual Stockholder Meeting
07:29pm, Thursday, 29'th Oct 2020
VALENCIA, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that
